Aspen Pharmacare Holdings Limited (APN.JO)
ZAc 16886.0
(1.41%)
ZAc 16886.0
(1.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.22 Billion | 5.52 Billion | 5.37 Billion | 6.82 Billion | 8.26 Billion | 6 Billion |
| Net Income | 6.99 Billion | 7.82 Billion | 8.67 Billion | 6.63 Billion | 7.42 Billion | 5.06 Billion |
| Depreciation & Amortization | 1.97 Billion | 1.78 Billion | 1.71 Billion | 1.65 Billion | 1.6 Billion | 1.27 Billion |
| Deferred income taxes | - | -435 Million | -1.63 Billion | -1.74 Billion | -882 Million | 1.13 Billion |
| Stock-based compensation | 117 Million | 135 Million | 62 Million | 67 Million | 50 Million | 37 Million |
| Change in working capital | -242 Million | -3.35 Billion | -2.65 Billion | 648 Million | 192 Million | -1.37 Billion |
| Other non-cash items | -1.74 Billion | -432 Million | -780 Million | -434 Million | -122 Million | -133 Million |
| Investing Cash Flow | -9.46 Billion | -3.42 Billion | -2.16 Billion | 9.76 Billion | 1.62 Billion | 3.23 Billion |
| Investments in PPE | -5.53 Billion | -3.18 Billion | -2.69 Billion | -3.43 Billion | -2.69 Billion | -3.58 Billion |
| Acquisitions | -911 Million | 317 Million | 73 Million | 12.76 Billion | 3.94 Billion | 12.29 Billion |
| Investment purchases | - | - | -469 Million | -740 Million | -389 Million | -1.29 Billion |
| Sales/Maturities of investments | - | - | 90 Million | 740 Million | 389 Million | 1.29 Billion |
| Other Investing Activities | -3.97 Billion | -557 Million | 842 Million | 426 Million | 368 Million | -5.47 Billion |
| Financing Cash Flow | 3.62 Billion | -420 Million | -4.67 Billion | -15.64 Billion | -11.46 Billion | -11.26 Billion |
| Debt repayment | -5.4 Billion | -6.58 Billion | -15.66 Billion | -30.07 Billion | -25.47 Billion | -33.12 Billion |
| Dividends payments | -1.52 Billion | -1.45 Billion | -1.19 Billion | - | - | -1.43 Billion |
| Common Stock Repurchased | -56 Million | -136 Million | -1.85 Billion | -50 Million | -41 Million | -29 Million |
| Common Stock Issuance | - | - | 17.51 Billion | - | - | 23.36 Billion |
| Other Financing Activities | -1.21 Billion | 7.75 Billion | -3.48 Billion | 14.47 Billion | 14.05 Billion | -41 Million |
| Accounts receivables | -104 Million | 327 Million | -1.35 Billion | 348 Million | 1.61 Billion | 869 Million |
| Accounts payables | -338 Million | -984 Million | 871 Million | 580 Million | -699 Million | -1.21 Billion |
| Inventory | 200 Million | -2.7 Billion | -2.16 Billion | -280 Million | -727 Million | -1.02 Billion |
| Other working capital | -338 Million | - | - | - | - | - |
| Cash at beginning of period | 7.49 Billion | 4.97 Billion | 5.95 Billion | 5.61 Billion | 6.14 Billion | 8.11 Billion |
| Cash at end of period | 7.22 Billion | 7.49 Billion | 4.97 Billion | 5.95 Billion | 5.61 Billion | 6.14 Billion |
| Capital Expenditure | -5.53 Billion | -3.18 Billion | -2.69 Billion | -3.43 Billion | -2.69 Billion | -3.58 Billion |
| Effect of forex changes on cash | -653 Million | 843 Million | 479 Million | -602 Million | 1.05 Billion | 59 Million |
| Net cash flow / Change in cash | -273 Million | 2.52 Billion | -984 Million | 338 Million | -531 Million | -1.96 Billion |
| Free Cash Flow | 690 Million | 2.33 Billion | 2.67 Billion | 3.39 Billion | 5.57 Billion | 2.41 Billion |
| Breakdown | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.09 Billion | 2.31 Billion | 1.15 Billion | 2.55 Billion | 7.82 Billion | 1.27 Billion |
| Depreciation & Amortization | 1.02 Billion | 944 Million | 472 Million | 928 Million | 1.78 Billion | 297.5 Million |
| Deferred income taxes | - | - | - | 1.11 Billion | -435 Million | 1.11 Billion |
| Stock-based compensation | 117 Million | - | - | 67.5 Million | 135 Million | 67.5 Million |
| Change in working capital | 184 Million | -88 Million | -44 Million | -1.19 Billion | -3.35 Billion | -103 Million |
| Other non-cash items | 347 Million | -712 Million | -356 Million | 3.37 Billion | -432 Million | 367.5 Million |
| Investing Cash Flow | -3.29 Billion | -6.17 Billion | -3.08 Billion | -1.83 Billion | -3.42 Billion | -916.5 Million |
| Investments in PPE | -1.62 Billion | -1.49 Billion | -746 Million | -2.06 Billion | -3.18 Billion | -697 Million |
| Acquisitions | -1.12 Billion | -3.22 Billion | -1.61 Billion | 176 Million | 317 Million | -71 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -552 Million | -1.44 Billion | -724.5 Million | 52 Million | -557 Million | -148.5 Million |
| Financing Cash Flow | -283 Million | 3.9 Billion | 1.95 Billion | -601 Million | -420 Million | -300.5 Million |
| Debt repayment | -171 Million | -5.48 Billion | - | -496 Million | -6.58 Billion | - |
| Dividends payments | - | -1.52 Billion | -762.5 Million | -4 Million | -1.45 Billion | -4 Million |
| Common Stock Repurchased | -4 Million | -52 Million | -26 Million | -4 Million | -136 Million | -2 Million |
| Common Stock Issuance | - | -94 Million | - | 199.5 Million | - | - |
| Other Financing Activities | -279 Million | 2.74 Billion | 2.74 Billion | -302.5 Million | 7.75 Billion | -294.5 Million |
| Accounts receivables | -104 Million | - | - | 163.5 Million | 327 Million | 163.5 Million |
| Accounts payables | - | - | - | -1.08 Billion | -984 Million | - |
| Inventory | 200 Million | - | - | -1.35 Billion | -2.7 Billion | -1.35 Billion |
| Other working capital | 88 Million | -88 Million | -44 Million | 1.08 Billion | - | 1.08 Billion |
| Cash at beginning of period | 7.62 Billion | 10.91 Billion | - | 8.04 Billion | 4.97 Billion | 5.31 Billion |
| Cash at end of period | 12.33 Billion | 7.62 Billion | 63.5 Million | 10.91 Billion | 7.49 Billion | 1.08 Billion |
| Capital Expenditure | -1.62 Billion | -1.49 Billion | -746 Million | -2.06 Billion | -3.18 Billion | -697 Million |
| Effect of forex changes on cash | -586 Million | -67 Million | -33.5 Million | 399.5 Million | 843 Million | 399.5 Million |
| Net cash flow / Change in cash | 4.71 Billion | -3.29 Billion | 63.5 Million | 2.86 Billion | 2.52 Billion | -4.22 Billion |
| Free Cash Flow | 2.14 Billion | 966 Million | 483 Million | 1.75 Billion | 2.33 Billion | 1.2 Billion |
CLW
601827
2851
IC8
1020
002480